Nitroglycerin Tablet
Product Images NDC 43598-435

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 43598-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

This is a product description for Nitroglycerin Sublingual Tablets USP, 0.4 mg/tablet. The tablets are dispensed in bottles of 25 and are intended for sublingual use only. Each tablet contains 0.4 mg of nitroglycerin. It is important to note that a "burning or tingling" sensation may occur upon tablet placement, and if pain persists after taking up to 3 tablets in a 15-minute period, prompt medical attention is recommended. The tablets should be stored at room temperature and kept out of reach of children. Additionally, the tablets should not be crushed, chewed, or swallowed. The manufacturer is Ingenus Pharmaceuticals NJ, LLC.*

FDA Label Image

Carton2 (Carton2)

Each tablet of this product contains 0.3 mg of nitroglycerin and must be stored in a container at a controlled room temperature between 20°C to 25°C (68°F to 77°F). It is essential to read the prescribing information as these tablets can cause side effects such as tingling sensations. If the pain persists after taking a dosage, which can include 3 tablets after 15 minutes, it is recommended to seek medical attention. Nitroglycerin sublingual tablets should not be crushed, chewed or swallowed.*

FDA Label Image

Carton3 (Carton3)

This is a medication label for Nitroglycerin Sublingual Tablets, USP 0.6 mg/tablet. It includes information on dosage, storage, and safety precautions. It also warns against chewing or swallowing the tablets and advises seeking medical attention if symptoms persist or worsen.*

FDA Label Image

Carton4 (Carton4)

FDA Label Image

Container1 (Container1)

This is a Nitroglycerin Sublingual tablet with a strength of 0.4 mg per tablet. The NDC number for this product is 43508-436-35. It is recommended to always dispense with the patient package insert. However, the last line of the text is not readable and may contain non-English characters.*

FDA Label Image

Container2 (Container2)

FDA Label Image

Container3 (Container3)

FDA Label Image

Container4 (Container4)

This is a description for Nitroglycerin Sublingual Tablets, 0.4 mg per tablet. It is available in a bottle of 100 sublingual tablets, with a prescription from Dr. Revov’s. The NDC number for this product is 43533-435-01. The other text seems to be unrelated and not readable.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.